Hubei Goto Biopharm Co.,Ltd. (SHE:300966)
China
· Delayed Price · Currency is CNY 17.12
+0.37 (2.21%)
May 16, 2025, 3:04 PM CST
Hubei Goto Biopharm Revenue
Hubei Goto Biopharm had revenue of 139.22M CNY in the quarter ending March 31, 2025, with 13.90% growth. This brings the company's revenue in the last twelve months to 553.58M, down -2.74% year-over-year. In the year 2024, Hubei Goto Biopharm had annual revenue of 536.60M, down -5.26%.
Revenue (ttm)
553.58M
Revenue Growth
-2.74%
P/S Ratio
3.57
Revenue / Employee
877.31K
Employees
631
Market Cap
1.97B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 29.19B |
| Shenzhen Mindray Bio-Medical Electronics | 35.59B |
| WuXi AppTec | 39.59B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
| Aier Eye Hospital Group | 21.81B |
| Shanghai United Imaging Healthcare | 10.43B |
| Sichuan Biokin Pharmaceutical | 5.82B |
| Yunnan Baiyao Group Co.,Ltd | 40.10B |